Health technology company Royal Philips has signed a five year $50m partnership agreement with South Jersey healthcare organisation Inspira Health to boost patient care and improve clinical workflow performance across Inspira’s network.

The agreement will help Inspira to standardise patient monitoring and improve diagnostic imaging solutions at more than a dozen facilities.

To provide better outcomes, as well as improved performance and patient and staff experience, the contract will include training and operational services to maximise Inspira’s operational efficacy.

Through the long-term strategic partnership, Philips will provide Inspira with its advanced diagnostic imaging solutions, patient care monitoring systems and minimally invasive solutions, such as the Philips Azurion image-guided therapy platform.

Inspira Health president and CEO John DiAngelo said: “At Inspira, we are focused on leveraging technology that enables our teams to provide the best possible care. By working closely with Philips, we have an opportunity to stay at the cutting edge of imaging and patient monitoring.

“This partnership will bring countless benefits to our patients, physicians and clinical teams. It comes down to ensuring that each individual community within our broader community is taken care of.”

The long-term strategic partnership is expected to help Inspira to standardise its diagnostic imaging and patient monitoring technologies while making data more integrated, enabling its clinicians to gain access to correct patient data for better diagnosis and treatment.

Inspira’s health system consists of three hospitals, a cancer centre, several multi-speciality health centres and a total of over 150 access points. It is also opening a hospital this month and a cancer centre in Mullica Hill, New Jersey in January 2020.